Literature DB >> 24124703

Common gastrointestinal symptoms: irritable bowel syndrome.

Julia Fashner1, Alfred Chege Gitu.   

Abstract

The diagnosis of irritable bowel syndrome (IBS) should be considered when patients have had abdominal pain/discomfort, bloating, and change in bowel habits for 6 months. Patients may experience variation between periods of constipation and diarrhea. When evaluating patients with IBS, physicians should be alert for red flag symptoms, such as rectal bleeding, anemia, nighttime pain, and weight loss. Physicians also should consider other medical conditions that manifest similarly to IBS. Clinicians who are confident in diagnosing IBS based on symptoms typically do not obtain many tests unless the patient has red flag symptoms. Various etiologic mechanisms have been proposed for IBS, including abnormal bowel motility, inflammation, altered mucosal permeability, genetic predisposition, and visceral hypersensitivity. Lack of certainty about the etiology makes it difficult to develop effective management approaches; thus, management is directed toward symptom relief. Dietary changes, such as avoiding fermentable carbohydrates, may benefit some patients, especially those with bloating. Constipation-dominant IBS can be managed with antispasmodics, lubiprostone, or linaclotide, whereas diarrhea-dominant IBS can be managed with loperamide or alosetron, though the latter drug can cause ischemic colitis. For long-term therapy, tricyclic antidepressants or selective serotonin reuptake inhibitors have good efficacy. Peppermint oil and probiotics also may provide benefit. Written permission from the American Academy of Family Physicians is required for reproduction of this material in whole or in part in any form or medium.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24124703

Source DB:  PubMed          Journal:  FP Essent        ISSN: 2159-3000


  2 in total

1.  Novel mixed NOP/MOP agonist BU08070 alleviates pain and inhibits gastrointestinal motility in mouse models mimicking diarrhea-predominant irritable bowel syndrome symptoms.

Authors:  Marta Sobczak; Gerta Cami-Kobeci; Maciej Sałaga; Stephen M Husbands; Jakub Fichna
Journal:  Eur J Pharmacol       Date:  2014-05-06       Impact factor: 4.432

2.  Wei Chang An pill regulates gastrointestinal motility in a bidirectional manner.

Authors:  Sitong Jia; Lijuan Chai; Jing Zhang; Min Zhang; Lin Li; Yaxin Qi; Yafen Pang; Xi Chen; Nana Fan; Lin Wang; Yujing Wang; Jixiang Song; Yingjie Sun; Yi Wang; Lin Miao; Han Zhang
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.